DEB - Dystrophic Epidermolysis Bullosa

Dermatology·MeSH: Corneal Injuries

Prevalence

0.5 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target DEB - Dystrophic Epidermolysis Bullosa?

There are 1 clinical trial targeting DEB - Dystrophic Epidermolysis Bullosa tracked by BioSniper.

What is the prevalence of DEB - Dystrophic Epidermolysis Bullosa?

The estimated prevalence of DEB - Dystrophic Epidermolysis Bullosa is approximately 0.5 per 100,000 population.

Deep-dive into DEB - Dystrophic Epidermolysis Bullosa

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    DEB - Dystrophic Epidermolysis Bullosa — Drugs in Development & Clinical Trials | BioSniper